Literature DB >> 6147519

Hepatitis B vaccination: how long does protection last?

W Jilg, M Schmidt, F Deinhardt, R Zachoval.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147519     DOI： 10.1016/s0140-6736(84)92926-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

1.  Laboratory techniques in the diagnosis and assessment of hepatitis B virus infection.

Authors:  J J Gray; T G Wreghitt
Journal:  Genitourin Med       Date:  1992-08

2.  Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.

Authors:  Q Mok; G Underhill; B Wonke; M Aldouri; M Kelsey; D Jefferies
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

3.  Duration of hepatitis B antibody response in children immunised with hepatitis B and compulsory vaccines.

Authors:  S Li Volti; G Giammanco-Bilancia; G Giammanco; F Mollica
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

4.  Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine.

Authors:  M T Pasko; T R Beam
Journal:  Am J Public Health       Date:  1990-05       Impact factor: 9.308

5.  Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years.

Authors:  Tino F Schwarz; Marek Spaczynski; Achim Schneider; Jacek Wysocki; Andrzej Galaj; Karin Schulze; Sylviane M Poncelet; Gregory Catteau; Florence Thomas; Dominique Descamps
Journal:  Hum Vaccin       Date:  2011-09-01

6.  Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure.

Authors:  G Pillion; M Chiesa; A Maisin; N Schlegel; C Loirat
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

7.  Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults.

Authors:  Jirí Beran; Lenka Hobzova; Veronika Wertzova; Sherine Kuriyakose; Maarten Leyssen; Murielle Surquin; Sophie Houard
Journal:  Hum Vaccin       Date:  2010-07-01

8.  Immunogenicity in humans of an edible vaccine for hepatitis B.

Authors:  Yasmin Thanavala; Martin Mahoney; Sribani Pal; Adrienne Scott; Liz Richter; Nachimuthu Natarajan; Patti Goodwin; Charles J Arntzen; Hugh S Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

Review 9.  The use of vaccines in renal failure.

Authors:  D W Johnson; S J Fleming
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

10.  Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia.

Authors:  Kalifa Bojang; Paul Milligan; Margaret Pinder; Tom Doherty; Amanda Leach; Opokua Ofori-Anyinam; Marc Lievens; Kent Kester; Kurt Schaecher; W Ripley Ballou; Joe Cohen
Journal:  Hum Vaccin       Date:  2009-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.